2012 Annual Meeting | NIH and the Practice of Neurology: Whats New? Whats Next?

Date Tuesday 04/24/12

Time 12:00 PM - 02:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Colloquium

Director(s) Walter J. Koroshetz, MD, FAAN

Topic(s)

Learning Objectives Participants should have a greater understanding of how recent clincial trials might impact practice and provide input to NIH and AAN leadership on important issues in neurology that are ripe for research.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic, Interactive

Program Evaluations

Event Timeline
12:00 PM - 12:15 PM		NIH and Neurology: Continuing the Dialogue Story C. Landis, PhD
12:00 PM - 02:00 PM		Break
12:15 PM - 12:35 PM		How the SAMMPRIS Trial Comparing Medical Therapy vs. Stenting in Patients with Intracranial Stenosis Affects Practice Marc I. Chimowitz, MD
12:35 PM - 12:55 PM		What Do Clinical Trials Tell Us About Mangement of Asymptomatic Carotid Disease Thomas G. Brott, MD, FAAN
12:55 PM - 01:00 PM		NINDS and the Practice of Neurology Walter J. Koroshetz, MD, FAAN
01:00 PM - 01:15 PM		Enhancing the Impact of NINDS Research on Neurology Timothy A. Pedley, MD, FAAN
01:15 PM - 01:30 PM		Training Academic Neurologists: the NINDS, AAN, ANA initiative Eva Feldman, MD, PhD, FAAN
01:30 PM - 01:45 PM		Research Priorities From the Practice Committee Jonathan P. Hosey, MD, FAAN
01:45 PM - 02:00 PM		Knowing What Works in the Real World of Neurology Practice Barbara G. Vickrey, MD, MPH, FAAN

Faculty Disclosures
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Jonathan P. Hosey, MD, FAAN	Dr. Hosey has nothing to disclose.
Story C. Landis, PhD	No disclosure on file
Timothy A. Pedley, MD, FAAN	No disclosure on file
Barbara G. Vickrey, MD, MPH, FAAN	The institution of Dr. Vickrey has received research support from NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a Grant reviewer, committee co-chair with NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a conference advisory committee with University of Rochester. Dr. Vickrey has a non-compensated relationship as a Second Vice President with Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee member of Stroke Council with American Heart Association that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee Chair with American Neurological Association that is relevant to AAN interests or activities.
Eva Feldman, MD, PhD, FAAN	The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities.
Marc I. Chimowitz, MD	An immediate family member of Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gore. Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo Inc. The institution of Dr. Chimowitz has received research support from NIH.
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.

��ɫ��

��ɫ��